P. Orsini, M. Salsa, S. Rizzi, U. Cucchi, D. Faiardi, A. Burocchi, A. Ciavolella, R. Lupi, F. Gasparri, B. Valsasina
AACR Annual Meeting 2024; April 5-10, 2024; San Diego
–Abstract 5805
Cancer Res (2024) 84 (6_Supplement)
Home / A novel platform of diversified cytotoxins and targeted payloads to drive ADC innovation
P. Orsini, M. Salsa, S. Rizzi, U. Cucchi, D. Faiardi, A. Burocchi, A. Ciavolella, R. Lupi, F. Gasparri, B. Valsasina
AACR Annual Meeting 2024; April 5-10, 2024; San Diego
–Abstract 5805
Cancer Res (2024) 84 (6_Supplement)
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.